Efficacy of standard rehabilitation in COPD outpatients with comorbidities

A prospective study was performed to confirm the prevalence pattern of the most frequent co-morbidities and to evaluate whether characteristics of patients, specific comorbidities and increasing number of comorbidities are independently associated with poorer outcomes in a population with complex chronic obstructive pulmonary disease (COPD) submitted for pulmonary rehabilitation (PR). 316 outpatients (mean±sd age 68±7 yrs) were studied. The outcomes recorded were comorbidities and proportion of patients with a pre-defined minimally significant change in exercise tolerance (6-min walk distance (6MWD) +54 m), breathlessness (Medical Research Council (MRC) score -1 point) and quality of life (St George’s Respiratory Questionnaire -4 points). 62% of patients reported comorbidities; systemic hypertension (35%), dyslipidaemia (13%), diabetes (12%) and coronary disease (11%) were the most frequent. Of these patients, >45% improved over the minimum clinically important difference in all the outcomes. In a logistic regression model, baseline 6MWD (OR 0.99, 95% CI 0.98–0.99; p = 0.001), MRC score (OR 12.88, 95% CI 6.89–24.00; p = 0.001) and arterial carbon dioxide tension (OR 1.08, 95% CI 1.00–1.15; p = 0.034) correlated with the proportion of patients who improved 6MWD and MRC, respectively. Presence of osteoporosis reduced the success rate in 6MWD (OR 0.28, 95% CI 0.11–0.70; p = 0.006). A substantial prevalence of comorbidities in COPD outpatients referred for PR was confirmed. Only the individual's disability and the presence of osteoporosis were independently associated with poorer rehabilitation outcomes.

[1]  Claudio Pedone,et al.  Comorbidities of chronic obstructive pulmonary disease , 2011, Current opinion in pulmonary medicine.

[2]  N. Ambrosino,et al.  Effects of early inpatient rehabilitation after acute exacerbation of COPD. , 2009, Respiratory medicine.

[3]  P. Paggiaro,et al.  Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. , 2009, Respiratory medicine.

[4]  P. J. Barnes,et al.  Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.

[5]  Frank C Sciurba,et al.  Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. , 2009, The American journal of medicine.

[6]  L. Fabbri,et al.  Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation , 2008, Thorax.

[7]  K. Rabe,et al.  Complex chronic comorbidities of COPD , 2008, European Respiratory Journal.

[8]  C. Weel,et al.  Non‐cardiovascular co‐morbidity in elderly patients with heart failure outnumbers cardiovascular co‐morbidity , 2007, European journal of heart failure.

[9]  Richard Casaburi,et al.  Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. , 2007, Chest.

[10]  Marta Benet,et al.  Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. , 2007, American journal of respiratory and critical care medicine.

[11]  Thierry Troosters,et al.  American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.

[12]  R. Stockley,et al.  Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype? , 2006, Respiratory research.

[13]  G. Frisoni,et al.  Predictive role of single diseases and their combination on recovery of balance and gait in disabled elderly patients. , 2006, Journal of the American Medical Directors Association.

[14]  F. Morell,et al.  Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy , 2006, European Respiratory Journal.

[15]  G. Davey Smith,et al.  The natural history of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[16]  Sally J. Singh,et al.  How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks , 2006, Thorax.

[17]  C. Prefaut,et al.  From muscle disuse to myopathy in COPD: potential contribution of oxidative stress , 2005, European Respiratory Journal.

[18]  Fabio Parazzini,et al.  Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists. , 2005, Seminars in arthritis and rheumatism.

[19]  C. Cooper,et al.  Severity of obstructive airway disease and risk of osteoporotic fracture , 2005, European Respiratory Journal.

[20]  D. Sin,et al.  Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. , 2005, Proceedings of the American Thoracic Society.

[21]  E. Clini,et al.  Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. , 2005, Chest.

[22]  D. Yach,et al.  The global burden of chronic diseases: overcoming impediments to prevention and control. , 2004, JAMA.

[23]  Corinna Hawkes,et al.  The global burden of chronic diseases. , 2004 .

[24]  W. Stalman,et al.  Comorbidity of somatic chronic diseases and decline in physical functioning:; the Longitudinal Aging Study Amsterdam. , 2004, Journal of clinical epidemiology.

[25]  F. Schellevis,et al.  The influence of co-morbidity on health-related quality of life in asthma and COPD patients. , 2003, Respiratory medicine.

[26]  M. Trabucchi,et al.  Medical Comorbidity and Complexity of the Rehabilitative Procedures for Older Patients with Functional Impairments , 2002, Journal of the American Geriatrics Society.

[27]  B. Celli,et al.  Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. , 2002, Chest.

[28]  P. Jones,et al.  Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.

[29]  E. Dekker,et al.  Added value of co-morbidity in predicting health-related quality of life in COPD patients. , 2001, Respiratory medicine.

[30]  M. Decramer,et al.  Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. , 2000, The American journal of medicine.

[31]  M. Smithson.  Statistics with confidence , 2000 .

[32]  K. Matsuzaki.  [Arterial carbon dioxide tension]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.

[33]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[34]  A. LaCroix,et al.  Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. , 1993, American journal of epidemiology.

[35]  I Russell,et al.  Statistics--with confidence? , 1991, The British journal of general practice : the journal of the Royal College of General Practitioners.

[36]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.